Moss Adams Wealth Advisors’s Avidity Biosciences RNAM Stock Holding History

Moss Adams Wealth Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,496	Closed	-$1.62M	–	288
2025 Q4	$1.62M	Hold	22,496	–	–	0.12%	54
2025 Q3	$980K	Hold	22,496	–	–	0.08%	77
2025 Q2	$639K	Hold	22,496	–	–	0.06%	114
2025 Q1	$664K	Hold	22,496	–	–	0.07%	91
2024 Q4	$654K	Hold	22,496	–	–	0.07%	86
2024 Q3	$1.03M	Sell	22,496 -15,717	-41%	-$682K	0.11%	55
2024 Q2	$1.56M	Buy	+38,213	New	+$1.1M	0.22%	39

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Moss Adams Wealth Advisors's RNAM Position: Q1 2026 in Review

Moss Adams Wealth Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 22,496 shares — an estimated $1.62M sold.

Moss Adams Wealth Advisors first reported a position in RNAM in Q2 2024 and held it in 7 quarters. The position peaked at $1.62M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Moss Adams Wealth Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Moss Adams Wealth Advisors sold 22,496 Avidity Biosciences shares in Q1 2026, an estimated $1.62M.
Moss Adams Wealth Advisors first reported a position in Avidity Biosciences in Q2 2024 and held it in 7 quarters.
Moss Adams Wealth Advisors's Avidity Biosciences position peaked at $1.62M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.